Three-gene predictor of clinical outcome for gastric cancer patients treated with chemotherapy

A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancer

(2009) Justin M Balko et al.   BMC CANCER

Nuclear expression of dynamin-related protein 1 in lung adenocarcinomas

(2009) Yung-Yen Chiang et al.   MODERN PATHOLOGY

Thymidylate synthase, dihydropyrimidine dehydrogenase, ERCC1, and thymidine phosphorylase gene expression in primary and metastatic gastrointestinal adenocarcinoma tissue in patients treated on a phase I trial of oxaliplatin and capecitabine

(2008) Kazumi Uchida et al.   BMC CANCER

Epidermal growth factor receptor structural alterations in gastric cancer

(2008) Cátia Moutinho et al.   BMC CANCER

Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples

(2008) Yasuhide Yamada et al.   CANCER SCIENCE

Clinical Determinants of Response to Irinotecan-Based Therapy Derived from Cell Line Models

(2008) W. L. Allen et al.   CLINICAL CANCER RESEARCH

Microarray-Based Prediction of Tumor Response to Neoadjuvant Radiochemotherapy of Patients With Locally Advanced Rectal Cancer

(2008) Caroline Rimkus et al.   Clinical Gastroenterology and Hepatology

Emerging drugs in the treatment of advanced gastric cancer

(2008) Eric D Tetzlaff et al.   EXPERT OPINION ON EMERGING DRUGS

Synergistic antitumor effect of S-1 and the epidermal growth factor receptor inhibitor gefitinib in non-small cell lung cancer cell lines: role of gefitinib-induced down-regulation of thymidylate synthase

(2008) T. Okabe et al.   MOLECULAR CANCER THERAPEUTICS